- Home
- ECF vs LSB Comparison
ECF vs LSB Comparison
Compare ECF & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECF
- LSB
- Stock Information
- Founded
- ECF 1986
- LSB 2002
- Country
- ECF United States
- LSB China
- Employees
- ECF N/A
- LSB 758
- Industry
- ECF Finance/Investors Services
- LSB
- Sector
- ECF Finance
- LSB
- Exchange
- ECF Nasdaq
- LSB NYSE
- Market Cap
- ECF 124.1M
- LSB 72.7M
- IPO Year
- ECF N/A
- LSB N/A
- Fundamental
- Price
- ECF $9.31
- LSB $3.86
- Analyst Decision
- ECF
- LSB
- Analyst Count
- ECF 0
- LSB 0
- Target Price
- ECF N/A
- LSB N/A
- AVG Volume (30 Days)
- ECF 57.7K
- LSB 130.1K
- Earning Date
- ECF 01-01-0001
- LSB 10-18-2024
- Dividend Yield
- ECF 6.42%
- LSB N/A
- EPS Growth
- ECF N/A
- LSB N/A
- EPS
- ECF 0.46
- LSB N/A
- Revenue
- ECF N/A
- LSB $79,415,311.00
- Revenue This Year
- ECF N/A
- LSB $39.33
- Revenue Next Year
- ECF N/A
- LSB $75.61
- P/E Ratio
- ECF $17.61
- LSB N/A
- Revenue Growth
- ECF N/A
- LSB N/A
- 52 Week Low
- ECF $7.02
- LSB $3.20
- 52 Week High
- ECF $8.91
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- ECF 71.89
- LSB 33.86
- Support Level
- ECF $8.87
- LSB $3.20
- Resistance Level
- ECF $9.00
- LSB $8.60
- Average True Range (ATR)
- ECF 0.12
- LSB 0.78
- MACD
- ECF 0.03
- LSB -0.52
- Stochastic Oscillator
- ECF 95.41
- LSB 11.67
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.